Banner_Prostate Cancer News

Novel Focal Ablation System Proceeds Through Prostate Cancer Pipeline

A group of scientists working in a lab

A streamline procedure allows treatment with the NanoTherm therapy system for focal ablation to be completed within 1 day.

Patient treatment has been completed in the initial part of stage 2 of a pivotal trial of the NanoTherm therapy system for the focal ablation of intermediate-risk prostate cancer, according to MagForce AG, the developer of the therapy.1

Read the full article here. 


source: Josh M. Broderick - Urology Times

decorative background image

Read More About Prostate Cancer

Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter.

Share